PMA Securities files amendment on municipal advisor registration
PMA Securities, LLC has filed an amendment related to its municipal advisor registration, reflecting its commitment to compliance in the financial services sector.
Union Bancaire Privee reveals $10.3B in latest holdings
Union Bancaire Privee, UBP SA discloses over $10.3 billion in assets in its latest filing, reflecting strategic investments in key sectors.
Tidal Trust II Files Post-Effective Amendment for ETF
Tidal Trust II has filed a post-effective amendment to its registration statement, marking a new effective date for its investment products.
UBS Group AG Amends Schedule 13G on Summit Hotel Properties
UBS Group AG's amended Schedule 13G shows no change in its ownership of Summit Hotel Properties, maintaining its position in the national commercial banking sector.
Aberdeen Group Increases Stake in Equillium to 7.03%
Aberdeen Group plc has increased its stake in Equillium, Inc. to 7.03%, reflecting growing interest in the pharmaceutical preparations sector.
Dierker Executes Major Stock Transactions at Church & Dwight
Richard A. Dierker, President and CEO of Church & Dwight Co., reports significant stock transactions, reflecting his active role in equity management.
TeraWulf Enters Google Backstop Agreement for Data Center Leases
TeraWulf Inc. announces a new agreement with Google to support its leases with Anthropic, enhancing operational stability and growth potential.
NewcelX Divests Legacy Mazindol Portfolio to REA Holdings
NewcelX Ltd. announces divestiture of its Mazindol portfolio to REA Holdings, focusing on core cell-therapy initiatives and potential milestone payments.
Harmony Biosciences reports Q3 2026 results and outlook
Harmony Biosciences Holdings, Inc. announces its Q3 2026 results, showcasing ongoing growth in the pharmaceutical preparations sector.
Septerna selects SEP-204 as development candidate for diseases
Septerna, Inc. announces SEP-204 as a candidate for Graves' disease and thyroid eye disease, with Phase 1 trials expected to start in early 2027.
Richard C. Young & CO., LTD. reports Q3 2026 holdings
Richard C. Young & CO., LTD. reveals its Q3 2026 investment holdings, showcasing a diverse portfolio across major companies.
Lloyds Banking Group unveils senior callable notes offering
Lloyds Banking Group plc has filed a preliminary prospectus for senior callable notes due in 2030 and 2032, aiming to enhance its capital structure.
Citigroup Announces New Unsecured Debt Securities Linked to Tesla
Citigroup Inc. has filed a preliminary pricing supplement for new unsecured debt securities linked to Tesla, aiming to enhance investor yields.
Jasper Therapeutics announces 1-for-30 reverse stock split
Jasper Therapeutics has filed for a 1-for-30 reverse stock split, effective November 6, 2026, aiming to enhance stock price and attract investors.
Processa Pharmaceuticals appoints Gregory Flesher as COO
Processa Pharmaceuticals has appointed Gregory J. Flesher as COO, effective November 4, 2026, to strengthen its operational leadership in the pharmaceutical sector.
Safehold Inc. reports Q3 results for 2026, shows steady growth
Safehold Inc. has released its Q3 2026 results, indicating steady growth in the real estate investment trust sector amid market challenges.
SmartRent Reports Q3 2026 Results, Highlights Growth
SmartRent, Inc. shares its Q3 2026 financial results, showing growth in integrated systems design services, impacting the tech industry positively.
HCA Inc. offers $6.5 billion in senior notes for refinancing
HCA Inc. has filed to offer $6.5 billion in senior notes, aimed at refinancing and corporate purposes, impacting the healthcare industry.
Critical Frontier SPV 3 LP Completes $6.3 Million Offering
Critical Frontier SPV 3 LP confirms $6.3 million offering completion, reflecting strong investor interest and impacting the venture capital sector.
Nuvectis Pharma reports Q3 results, outlines future plans
Nuvectis Pharma, Inc. releases Q3 results, detailing financial performance and future strategies in the pharmaceutical industry.